TRIAMINIC-D MULTI-SYMPTOM COLD OTC
Generic Name and Formulations:
Chlorpheniramine maleate 1mg, dextromethorphan HBr 7.5mg, pseudoephedrine HCl 15mg; per 5mL; liq; grape flavor; contains sodium 6mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC-D MULTI-SYMPTOM COLD:
Nasal and sinus congestion. Cough. Rhinorrhea. Itchy nose or throat.
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL every 6 hours as needed. Max 4 doses/24hrs.
Children <4yrs old. During or within 14 days of MAOIs. Use as a sedative hypnotic.
Heart disease. Hypertension. Thyroid disease. Diabetes. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist for ≥7 days.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Antihistamine + antitussive + sympathomimetic.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Elevated Dopamine Synthesis Capacity Observed in Both Bipolar and Schizophrenia
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Specialty Physicians Experiencing Lack of Income Growth
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV